scholarly journals Tyrphostin AG126 exerts neuroprotection in CNS inflammation by a dual mechanism

Glia ◽  
2015 ◽  
Vol 63 (6) ◽  
pp. 1083-1099 ◽  
Author(s):  
Christiane Menzfeld ◽  
Michael John ◽  
Denise van Rossum ◽  
Tommy Regen ◽  
Jörg Scheffel ◽  
...  
Keyword(s):  
Cns Inflammation ◽  
Dual Mechanism ◽  
Tyrphostin Ag126

PBIMA Immuno-Molecular Augmentation Progressive CNS Inflammation Autoimmune Disease Final Sample Report

2019 ◽  
Vol 1 (1) ◽  
pp. 010-015
Author(s):  
Anton Yuryev Yuryev ◽  
◽  
John Catanzaro ◽  
Md Shamsuddin Sultan Khan ◽  
◽  
...  
Keyword(s):  
Autoimmune Disease ◽  
Cns Inflammation ◽  
Final Sample

Development of Personalized Therapeutics Using Neo7logix® Precision Profiling for Progressive CNS Inflammation And Autoimmune Disease

2019 ◽  
Vol 1 (1) ◽  
pp. 001-006
Author(s):  
Anton Yuryev ◽  
◽  
John Catanzaro ◽  
Md Shamsuddin Sultan Khan ◽  
◽  
...  
Keyword(s):  
Autoimmune Disease ◽  
Cns Inflammation

Therapeutic Targets for the Treatment of Comorbidities Associated with Epilepsy

2020 ◽  
Vol 13 (2) ◽  
pp. 85-93
Author(s):  
Kinjal Gangar ◽  
Lokesh Kumar Bhatt
Keyword(s):  
Attention Deficit Hyperactivity Disorder ◽  
Attention Deficit ◽  
Neurological Disorders ◽  
Therapeutic Targets ◽  
Therapeutic Failure ◽  
Hyperactivity Disorder ◽  
Novel Targets ◽  
New Therapeutic Targets ◽  
Dual Mechanism ◽  
Seizure Suppression

One of the most common neurological disorders, which occurs among 1% of the population worldwide, is epilepsy. Therapeutic failure is common with epilepsy and nearly about 30% of patients fall in this category. Seizure suppression should not be the only goal while treating epilepsy but associated comorbidities, which can further worsen the condition, should also be considered. Treatment of such comorbidities such as depression, anxiety, cognition, attention deficit hyperactivity disorder and, various other disorders which co-exist with epilepsy or are caused due to epilepsy should also be treated. Novel targets or the existing targets are needed to be explored for the dual mechanism which can suppress both the disease and the comorbidity. New therapeutic targets such as IDO, nNOS, PAR1, NF-κb are being explored for their role in epilepsy and various comorbidities. This review explores recent therapeutic targets for the treatment of comorbidities associated with epilepsy.

Nonuniform Hyper-Network Embedding with Dual Mechanism

2020 ◽  
Vol 38 (3) ◽  
pp. 1-18
Author(s):  
Jie Huang ◽  
Chuan Chen ◽  
Fanghua Ye ◽  
Weibo Hu ◽  
Zibin Zheng
Keyword(s):  
Network Embedding ◽  
Dual Mechanism

Structural Analysis and Performance in a Dual‐Mechanism Conductive Filament Memristor

2021 ◽  
pp. 2100605
Author(s):  
Shu‐Chin Tsai ◽  
Hong‐Yang Lo ◽  
Chih‐Yang Huang ◽  
Min‐Ci Wu ◽  
Yi‐Tang Tseng ◽  
...  
Keyword(s):  
Structural Analysis ◽  
Conductive Filament ◽  
And Performance ◽  
Dual Mechanism

A dual mechanism for intrinsic f0

2021 ◽  
Vol 87 ◽  
pp. 101063
Author(s):  
Wei-Rong Chen ◽  
D.H. Whalen ◽  
Mark K. Tiede
Keyword(s):  
Dual Mechanism
Sign in / Sign up

Export Citation Format

Share Document